← Back to Search

Behavioural Intervention

SMS Intervention for ADHD

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights

Study Summary

This trial will test whether twice-daily text messages can improve adherence to stimulants in adults with ADHD.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to Stimulants

Trial Design

1Treatment groups
Experimental Treatment
Group I: SMS InterventionExperimental Treatment1 Intervention
All subjects will receive customized text messages twice a day, every day for 9 months that will include reminders to adhere to the individualized medication regimen, reminders to call their clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,238 Total Patients Enrolled
59 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
8,422 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Shire Human Genetic Therapies, Inc.Industry Sponsor
5 Previous Clinical Trials
5,210 Total Patients Enrolled

Media Library

SMS Intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04189575 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: SMS Intervention
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: SMS Intervention Highlights & Side Effects. Trial Name: NCT04189575 — N/A
SMS Intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04189575 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Patient Testimony for trial: Trial Name: NCT04189575 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being accepted into this experiment?

"At the moment, clinicaltrials.gov indicates that this research is not in search of participants; it was initially posted on May 24th 2018 and last updated September 22nd 2022. Nonetheless, there are 156 other trials currently recruiting patients."

Answered by AI

Are there any qualifications that would enable me to partake in this trial?

"This clinical study is accepting 117 patients, aged 18-55, who have been diagnosed with Attention Deficit Disorder. In addition to meeting these requirements, participants must also own a mobile device capable of text messaging and be fluent in English. Furthermore, they are required to already possess a valid prescription for stimulant medication from their GP or psychiatrist."

Answered by AI

Is participation in this experiment restricted to those over sixty or can younger individuals participate?

"This clinical trial requires that all potential participants are between 18 and 55 years of age."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
Massachusetts
How old are they?
18 - 65
What site did they apply to?
Massachusetts General Hospital
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
2
3+

Why did patients apply to this trial?

Diagnosed very late in life and still searching for ways to improve quality of life in addition to finding the right medication.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting
Joseph Biederman, MD 2018. "A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04189575.
All > Adhd
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top